KPIs & Operating Metrics(New)
Breakdown Of AssetsCost Of RevenueDiaggregated Revenue AnnualDiaggregated Revenue Mix Annual %Disaggregated RevenueDisaggregated Revenue Mix %Employee StatisticsIncome Before Provisions For Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX BreakdownProfitability AnnualProperty And Equipment, NetRevenueRevenue AnnualRevenue From PayorsRevenue From Payors AnnualRevenue Mix From Payors %Revenue Mix From Payors Annual %Test Reports DeliveredTest Reports Delivered BreakdownTest Reports Delivered Total
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Revenue (2018 - 2025)

Castle Biosciences' Revenue history spans 7 years, with the latest figure at $87.0 million for Q4 2025.

  • For Q4 2025, Revenue rose 0.81% year-over-year to $87.0 million; the TTM value through Dec 2025 reached $344.2 million, up 3.66%, while the annual FY2025 figure was $344.2 million, 3.66% up from the prior year.
  • Revenue for Q4 2025 was $87.0 million at Castle Biosciences, up from $83.0 million in the prior quarter.
  • Across five years, Revenue topped out at $88.0 million in Q1 2025 and bottomed at $22.8 million in Q2 2021.
  • The 5-year median for Revenue is $55.8 million (2023), against an average of $56.4 million.
  • The largest annual shift saw Revenue soared 78.99% in 2021 before it fell 3.19% in 2025.
  • A 5-year view of Revenue shows it stood at $25.0 million in 2021, then skyrocketed by 53.11% to $38.3 million in 2022, then soared by 72.47% to $66.1 million in 2023, then surged by 30.54% to $86.3 million in 2024, then grew by 0.81% to $87.0 million in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Revenue are $87.0 million (Q4 2025), $83.0 million (Q3 2025), and $86.2 million (Q2 2025).